NEWS
Institutional Subscription: Comprehensive Analyses to Enhance Your Global and Local Impact
New Feature: Compare Your Institution with the Previous Year
Find a Professional: Explore Experts Across 197 Disciplines in 220 Countries!
Find a Professional
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
person
Find a Professional
Péter Lakatos
Semmelweis University Budapest - Budapest / Hungary
Others
AD Scientific Index ID: 4993993
Semmelweis University
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Subject Leaders
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Péter Lakatos's MOST POPULAR ARTICLES
1-)
Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis DM Black, PD Delmas, R Eastell, IR Reid, S Boonen, JA Cauley, ... New England Journal of Medicine 356 (18), 1809-1822, 2007 36632007
2-)
Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised …DL Kendler, F Marin, CAF Zerbini, LA Russo, SL Greenspan, V Zikan, ...The Lancet 391 (10117), 230-240, 20185192018
3-)
Efficacy and tolerability of once-monthly oral ibandronate in postmenopausal osteoporosis: 2 year results from the MOBILE studyJY Reginster, S Adami, P Lakatos, M Greenwald, JJ Stepan, SL Silverman, ...Annals of the rheumatic diseases 65 (5), 654-661, 20065172006
4-)
Romosozumab (sclerostin monoclonal antibody) versus teriparatide in postmenopausal women with osteoporosis transitioning from oral bisphosphonate therapy: a randomised, open …BL Langdahl, C Libanati, DB Crittenden, MA Bolognese, JP Brown, ...The Lancet 390 (10102), 1585-1594, 20174432017
5-)
Epidemiology and diagnosis of hypoparathyroidismBL Clarke, EM Brown, MT Collins, H Jüppner, P Lakatos, MA Levine, ...The Journal of Clinical Endocrinology & Metabolism 101 (6), 2284-2299, 20163852016
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept